This is a discussion board initial posting. I do not need a title page. 

RESOURCES:

• Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th Ed.) Cambridge University Press.
  • -Chapter 2, “Transporters, Receptors, and Enzymes as Targets of Psychopharmacological Drug Action” (pp. 29-50)
  • -Chapter 3, “Ion Channels as Targets of Psychopharmacological Drug Action) (pp. 51-76)

• -the University of British Columbia. (n. d.). Neuroanatomy videosLinks to an external site.. http://neuroanatomy.ca/videos.htmlNote: Please review all of the media under the neuroanatomy series.
•  
• -Mental Health TV. (2022, Oct 7).  Psychopharmacology-Module fourLinks to an external site. [Video]. YouTube. https://www.youtube.com/watch?v=46Ioy6SSta4&t=89s
•  
• -Mental Health TV. (2022, Oct 7).  Psychopharmacology-Module five [Video]. YouTube. https://www.youtube.com/watch?v=1ynTQB59KW0&t=16s
•  

ASSIGNMENT:

Post a response to each of the following:

1. 1.) Explain the agonist-to-antagonist spectrum of action of psychopharmacologic agents, including how partial and inverse agonist functionality may impact the efficacy of psychopharmacologic treatments.
2.  
3. 2.) Compare and contrast the actions of g couple proteins and ion gated channels.
4.  
5. 3.) Explain how the role of epigenetics may contribute to pharmacologic action.
6.  
7. 4.) Explain how this information may impact the way you prescribe medications to patients. Include a specific example of a situation or case with a patient in which the psychiatric mental health nurse practitioner must be aware of the medication’s action.